News

Quality of life: Primary Debulking Surgery versus Neo-adjuv...

Quality of life: Primary Debulking Surgery versus Neo-adjuvant Chemotherapy

November 5, 2013

An international group of researchers examined quality of life factors for ovarian cancer patients enrolled in a large European clincial trial (EORTC 55971).  They compared the quality of life patients who had primary debulking surgery versus those who had neo-adjuvant chemotherapy, followed by surgery. The results, which are published in the journal Gynecologic Oncology, showed … Continued

New Study find Hot Ovarian Cancer Cells are Easier to Kill

New Study find Hot Ovarian Cancer Cells are Easier to Kill

October 23, 2013

Oregon State University researchers have found that using nanotechnology with heat and cytotoxic drugs can kill up to 95% of ovarian cancer cells.  While there is still additional research that needs to be done, the results of the initial study are promising for the future of ovarian cancer treatments.  Read full article here.

New Clue in BRCA1 and BRCA2 Mutations

New Clue in BRCA1 and BRCA2 Mutations

October 18, 2013

A new study released in Lancet Oncology showed that abnormal levels of female hormones in the bloodstream may be why women with BRCA1 or BRCA2 mutations are at a higher risk for breast and ovarian cancer and not other cancers.  UCL Department of Women’s Cancer completed the study that found different levels of the female hormones … Continued

DNA "Tags" Could Guide Treatment

DNA "Tags" Could Guide Treatment

October 17, 2013

A new study conducted by Cancer Research UK has identified chemical “tags” on DNA in patients’ tumors that could help doctors decide the type of chemotherapy women with advanced ovarian cancer should receive.  The research was published in Clinical Cancer Research. These tags, known as epigenetic markers, could be used to assess whether patients will … Continued

New Discovery of Inflammation Process of Some Ovarian Cance...

New Discovery of Inflammation Process of Some Ovarian Cancer Tumors Could Help Expand Treatment

October 16, 2013

A study led by Dr. Andrew Stephens from the Prince Henry’s Institute has discovered a process that is associated with inflammation in cancers.  This discovery could lead to expanded treatment options for some types of ovarian cancer tumors.  Monash Health, Hasanuddin University, Indonesia and Lincoln Research Centre, Christchurch also participated in the study which was … Continued

Ovarian Cancer News from the European Cancer Congress

Ovarian Cancer News from the European Cancer Congress

October 7, 2013

The European Cancer Congress convened in Amsterdam, the Netherlands from September 27 – October 1, 2013.  The European Cancer Congress in the main multidisciplinary and multi-professional educational meeting in oncology to take place in Europe. At ECCO, cancer specialists from around the world convene to present their research.  In this story on Medscape, Dr. Stanley … Continued

Association between Marriage Status and Improved Cancer Out...

Association between Marriage Status and Improved Cancer Outcomes

October 2, 2013

Research published in Sept. 2013 in the Journal of Clinical Oncology show that patients with cancer who were married at the time of diagnosis live markedly longer compared to unmarried patients. The results, based on a large retrospective study of the National Cancer Institute’s SEER database, also report that married patients are more likely to … Continued

Q&A with Ron Chandler, Ph.D.

Q&A with Ron Chandler, Ph.D.

September 24, 2013

Dr. Ron Chandler is a 2013 Ann Schreiber Mentored Investigator Award recipient. In this interview with OCRF’s Sarah DeFeo, Dr. Chandler discusses his research and what it means to receive a grant from OCRF. Sarah DeFeo:  Tell us about yourself. Ron Chandler:  I am the first Ph.D. scientist in my family, although my Grandpa and Dad … Continued

MD Anderson: Versatile microRNAs choke off cancer blood sup...

MD Anderson: Versatile microRNAs choke off cancer blood supply, suppress metastasis

September 11, 2013

A new study released today by MD Anderson Cancer Center in Texas shows that a family of microRNAs (miR-200) blocks cancer progression by cutting off the tumor’s ability to build new blood vessels.  These findings highlight the potential of biomarkers for identifying patients who might benefit from treatment.  Dr. Anil Sood says “safety studies will need … Continued

Press Release: New Report Offers Patient Perspectives on Ov...

Press Release: New Report Offers Patient Perspectives on Ovarian Cancer Treatment, Diagnosis

September 11, 2013

Washington, DC—A new report released by the Ovarian Cancer National Alliance summarizes the experiences of 1,014 women diagnosed with ovarian cancer. Based on a survey conducted by the Alliance in partnership with Inspire, the report details how women were diagnosed and whether their treatment followed national guidelines for ovarian cancer. The survey was inspired by … Continued

Q&A with Maria Barbolina, Ph.D.

Q&A with Maria Barbolina, Ph.D.

September 11, 2013

Dr. Maria Barbolina is a 2013 Liz Tilberis Early Career Award grant recipient. In this interview with OCRF’s Sarah DeFeo, Dr. Barolina discusses her research and what it means to receive a grant from OCRF. Sarah DeFeo:  Tell us a little about yourself. Maria Barbolina:  I live in Chicago now, but my life started on the … Continued

Ovarian Tissue Transplant followed by Successful IVF Create...

Ovarian Tissue Transplant followed by Successful IVF Creates Future Fertility Hope for Ovarian Cancer Survivors

September 10, 2013

An ovarian cancer survivor in Australia, Vali, is 26-weeks pregnant after being told she was infertile due to ovarian cancer treatments. “The sample of Vali’s ovarian tissue was taken from her cancer-free ovary through keyhole surgery and frozen. Seven years later, the tissue was grafted onto the left and right sides of the front wall … Continued